This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Recently, the notorious conspiracy theory peddler Alex Jones shared an “Infowars” video on X lambasting the “horrific side effects” of Covid vaccines: “Yale scientists link COVID vaccines to alarming new syndrome causing distinct biological changes to the body,” his post read. News of the new study spread like wildfire throughout right-wing anti-vaccine circles, amplified by the likes of Alex Berenson , Elon Musk , and Joe Rogan , who touted the study as
In early January, I received a letter in the mail from the Wisconsin Department of Health Services. The letter informed me that I had been approved for Medicaid-funded Home and Community-Based Services (HCBS), a form of long-term care. It had been five months since I’d applied to the program, after being discharged from the hospital in August 2024 as a new full-time wheelchair user.
Breaking Down Barriers: The Power of Global Research Collaborations in Generic Drug Development As the world grapples with the complexities of healthcare, one thing is clear: the need for innovative solutions has never been more pressing. In the realm of generic drug development, international research collaborations are emerging as a game-changer. By pooling resources, expertise, and knowledge, researchers from around the globe can accelerate the discovery of life-saving treatments and make the
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
The Department of Justice is investigating Semler Scientific for possible violations of a federal anti-fraud law related to its marketing of a product known as QuantaFlo, a test used in the diagnosis of peripheral artery disease by UnitedHealth Group and other large insurers. In a recent filing with the Securities and Exchange Commission, Semler disclosed that the government is investigating the use of QuantaFlo related to claims made for reimbursement from government health programs, which in s
Just over half (52%) of the pharmacies participating in Pharmacy First met the monthly threshold of 20 clinical pathways in November, analysis by The Pharmacistsuggests. This puts the scheme in a slightly healthier position than the previous two months, when fewer than half of participating pharmacies met the thresholds after they rose to 20 in […] The post More pharmacies meet Pharmacy First thresholds as seasonal ailments rise appeared first on The Pharmacist.
WASHINGTON — The top spokesman at the Department of Health and Human Services abruptly resigned Friday following tensions with Secretary Robert F. Kennedy Jr. and his team, according to two people familiar with his departure. Thomas Corry, who had only recently taken on the role of assistant secretary for public affairs, announced his immediate departure on Monday.
350
350
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
WASHINGTON — The top spokesman at the Department of Health and Human Services abruptly resigned Friday following tensions with Secretary Robert F. Kennedy Jr. and his team, according to two people familiar with his departure. Thomas Corry, who had only recently taken on the role of assistant secretary for public affairs, announced his immediate departure on Monday.
A team of researchers in Japan have developed a novel artificial photosynthesis method that transforms waste organic compounds into valuable pharmaceuticals and energy using sunlight and water. The approach, known as artificial photosynthesis directed toward organic synthesis (APOS), represents a major step forward in sustainable chemical manufacturing.
Sutter Health has agreed to settle a massive class-action lawsuit accusing the nonprofit health system of illegally wielding its market power to drive up Californians’ health care costs by more than $400 million. The long-running federal lawsuit was settled on the eve of trial on Sunday. It would have been the second time the case, Sidibe v. Sutter Health, was tried before a jury.
OneSource Specialty Pharma announced the appointment of three new non-executive independent directors to its Board Dr Claudio Albrecht, Debarati Sen and Vijay Karwaleffective February 27, 2025. The directors bring leadership experience and expertise in pharma, business strategy, transformation, and M&As among others. With the appointment of these non-executive directors, the OneSource Board now comprises: Chairperson: Arun Kumar Founder and Non-Executive Director Independent Directors: Dr
This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here. Hello and welcome. I’ll tell ya what. Nothing says “radical transparency” like making a federal agency’s processes less transparent. You know where you can always submit public comments?
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Welcome to the 2025 edition of STAT Madness, our bracket-style competition in which you, the readers, choose the most impressive biomedical and health research published last year. Voting begins today. Modeled on college basketball’s March Madness tournament, STAT Madness is meant to be fun, but it also has a serious purpose: highlighting important scientific advances emerging from labs at the nation’s universities, medical schools, and other U.S. research institutions and companie
Unlock the Power of Google Patents for Drug Patent Research As a researcher or professional in the pharmaceutical industry, staying on top of the latest developments in drug patents is crucial for making informed decisions. But with the vast amount of information available, it can be overwhelming to know where to start. That's where Google Patents comes in a powerful tool that can help you streamline your research and uncover valuable insights.
More than a decade ago, Ken Mandl was on a call with a pharmaceutical company and the leader of a social network for people with diabetes. The drug maker was hoping to use the platform to encourage its members to get a certain lab test. The test could determine a patient’s need for a helpful drug. But in that moment, said Mandl, director of the computational health informatics program at Boston Children’s Hospital, “I could see this focus on a biomarker as a way to inc
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The oral Factor B inhibitor of the alternative complement pathway is designed for this rare kidney condition with no approved treatments, which significantly impacts young individuals’ lives. The CHMP’s positive opinion is grounded in the outcomes from the Phase III trial, APPEAR-C3G. Fabhalta demonstrated a 35.1% decrease in proteinuria at six months against a placebo.
After a Canadian regulator began requiring application fees from drug companies more than a decade ago, the odds that a drug — other than cancer treatments — would receive a recommendation for government funding rose dramatically, according to a new study. And the author suggested the fees created a conflict of interest that may have influenced agency decision-making.
An experimental medicine from Protagonist Therapeutics stabilized red blood cells and improved symptoms in patients with a rare blood cancer — achieving the efficacy goals of a Phase 3 study. Based on the positive study results, announced Monday, Protagonist and its partner Takeda will submit the drug, called rusfertide, for approval in the U.S. and Europe later this year.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The obesity medicine field has gained a new entrant, with AbbVie on Monday announcing it had licensed an experimental weight loss drug from a Danish company that is in a Phase 1 trial. The deal includes a $350 million upfront payment to the company, Gubra, for the rights to its drug, called for now GUB014295. AbbVie will pay up to some $1.9 billion if certain development and sales milestones are met.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! I’m not huge on gamification, except in three instances: my Survivor fantasy league, Oscars predictions, and the STAT Madness competition. This week, I am getting to participate in all three. Voting is open for STAT’s annual bracket-style competition in which readers choose the most impressive biomedical and health research published last yea
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
March 2025 Event Professionals Affinity Group Meeting Event Time: 12:00 - 1:00 p.m. ET Event Location: Virtual NHC Event Professionals Affinity Group Meeting: Supporting Health and Wellness at Events The NHCs Event Professionals Affinity Group consists of meeting and event planners who organize events for NHC member organizations, including patient organizations that advocate for people and their family caregivers living with chronic diseases and disabilities.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and reassuring. After all, that oh-so familiar routine of phone calls, online meetings, and lengthening to-do lists has returned with a vengeance. Such are the signs of progress, we hope. To cope, yes, we are brewing cups of stimulation and our choice today is maple French toast cinnamon.
The American Conference Institutes 3rd Annual Forum on Advanced Therapeutics is scheduled to take place from March 19-20, 2025, at the Seaport Hotel in Boston, MA. The conference will bring together industry leaders to explore evolving market trends, regulatory frameworks, and intellectual property strategies shaping the future of advanced therapeutics.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we bid adieu to NIH luminary Francis Collins. Also, lots of updates on vaccines, and Ginkgo starts subleasing its lab space.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that. Pyronaridine has been used to treat the mosquito-borne infectious disease for over 30 years. The discovery is the result of a serendipitous encounter at UTEP.
A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with drugs from Novo Nordisk, Eli Lilly and Zealand.
Panelists discuss how pharmacists employ multiple strategies to support medication adherence in older adults with TD, including simplifying dosing regimens, utilizing medication synchronization programs, providing medication packaging solutions, conducting regular follow-up calls, and collaborating closely with prescribers and care teams to develop and adjust personalized treatment plans that address individual patient needs and barriers to care.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
362 
Let's personalize your content